Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients


Published in:
Annals Of Oncology, 29, 40-40
Presented at:
ESMO Immuno-Oncology Congress, Geneva, SWITZERLAND, Dec 13-16, 2018
Year:
Dec 01 2018
Publisher:
Oxford, OXFORD UNIV PRESS
ISSN:
0923-7534
1569-8041




 Record created 2019-06-18, last modified 2019-08-12


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)